212 related articles for article (PubMed ID: 6779699)
1. Topical and systemic antimicrobial agents in burns.
Ollstein RN; McDonald C
Ann Plast Surg; 1980 Nov; 5(5):386-92. PubMed ID: 6779699
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic prophylaxis and therapy in burns.
Gillett AP
J Hosp Infect; 1985 Sep; 6 Suppl B():59-66. PubMed ID: 2865312
[No Abstract] [Full Text] [Related]
3. Full-thickness porcine burns infected with Staphylococcus aureus or Pseudomonas aeruginosa can be effectively treated with topical antibiotics.
Tsai DM; Tracy LE; Lee CC; Hackl F; Kiwanuka E; Minasian RA; Onderdonk A; Junker JP; Eriksson E; Caterson EJ
Wound Repair Regen; 2016 Mar; 24(2):356-65. PubMed ID: 26800421
[TBL] [Abstract][Full Text] [Related]
4. [Changes in the microflora of burn wounds after local treatment].
Perekhrestenko PM; Nam L; Litovchenko PP; Keĭsevich LV
Klin Khir (1962); 1991; (3):24-5. PubMed ID: 1906124
[No Abstract] [Full Text] [Related]
5. The microbiology of crocodile attacks in Far North Queensland: implications for empirical antimicrobial therapy.
Smith S; Bagshaw RJ; Hanson J
Med J Aust; 2017 Apr; 206(7):307-308. PubMed ID: 28403763
[No Abstract] [Full Text] [Related]
6. Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci.
Strock LL; Lee MM; Rutan RL; Desai MH; Robson MC; Herndon DN; Heggers JP
J Burn Care Rehabil; 1990; 11(5):454-9. PubMed ID: 2123203
[TBL] [Abstract][Full Text] [Related]
7. Nanoemulsion Therapy for Burn Wounds Is Effective as a Topical Antimicrobial Against Gram-Negative and Gram-Positive Bacteria.
Dolgachev VA; Ciotti SM; Eisma R; Gracon S; Wilkinson JE; Baker JR; Hemmila MR
J Burn Care Res; 2016; 37(2):e104-14. PubMed ID: 26182074
[TBL] [Abstract][Full Text] [Related]
8. [Hygiene and wound bacteriology].
Fromantin I
Soins; 2006 Oct; (709):19-20, 22. PubMed ID: 17111861
[No Abstract] [Full Text] [Related]
9. Immediate Treatment of Burn Wounds with High Concentrations of Topical Antibiotics in an Alginate Hydrogel Using a Platform Wound Device.
Nuutila K; Grolman J; Yang L; Broomhead M; Lipsitz S; Onderdonk A; Mooney D; Eriksson E
Adv Wound Care (New Rochelle); 2020 Feb; 9(2):48-60. PubMed ID: 31903298
[No Abstract] [Full Text] [Related]
10. Infection in burns.
Settle JA
J Hosp Infect; 1985 Sep; 6 Suppl B():19-29. PubMed ID: 2865307
[No Abstract] [Full Text] [Related]
11. [Optimal control of the microflora environment in suppurative foci].
Menshikov DD; Oleĭnik VA; Ianisker EG; Kumacheva EG; Zalogueva GV; Finogenova LG; Enileva RKh
Antibiot Khimioter; 1990 Jul; 35(7):44-7. PubMed ID: 2126707
[TBL] [Abstract][Full Text] [Related]
12. Next science wound gel technology, a novel agent that inhibits biofilm development by gram-positive and gram-negative wound pathogens.
Miller KG; Tran PL; Haley CL; Kruzek C; Colmer-Hamood JA; Myntti M; Hamood AN
Antimicrob Agents Chemother; 2014 Jun; 58(6):3060-72. PubMed ID: 24637684
[TBL] [Abstract][Full Text] [Related]
13. Targeting bacterial adherence inhibits multidrug-resistant Pseudomonas aeruginosa infection following burn injury.
Huebinger RM; Stones DH; de Souza Santos M; Carlson DL; Song J; Vaz DP; Keen E; Wolf SE; Orth K; Krachler AM
Sci Rep; 2016 Dec; 6():39341. PubMed ID: 27996032
[TBL] [Abstract][Full Text] [Related]
14. The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis.
Glik J; Kawecki M; Gaździk T; Nowak M
Pol Przegl Chir; 2012 Jan; 84(1):6-16. PubMed ID: 22472489
[TBL] [Abstract][Full Text] [Related]
15. A novel in vitro flat-bed perfusion biofilm model for determining the potential antimicrobial efficacy of topical wound treatments.
Thorn RM; Greenman J
J Appl Microbiol; 2009 Dec; 107(6):2070-9. PubMed ID: 19548886
[TBL] [Abstract][Full Text] [Related]
16. Methenamine salts as topical antibacterial agent. I. Experimental studies for burn and crush wound.
Matsumoto T; Wolferth CC; Hayes MF
Arch Surg; 1970 Jul; 101(1):71-7. PubMed ID: 4911675
[No Abstract] [Full Text] [Related]
17. Infection in burn patients in a referral center in Colombia.
Ramirez-Blanco CE; Ramirez-Rivero CE; Diaz-Martinez LA; Sosa-Avila LM
Burns; 2017 May; 43(3):642-653. PubMed ID: 28185802
[TBL] [Abstract][Full Text] [Related]
18. Bacteriological cultures on admission of the burn patient: To do or not to do, that's the question.
Dokter J; Brusselaers N; Hendriks WD; Boxma H
Burns; 2016 Mar; 42(2):421-7. PubMed ID: 26777453
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Pseudomonas and Staphylococcus wound isolates to topical antimicrobial agents: a 10-year review and clinical evaluation.
Thomson PD; Taddonio TE; Tait MJ; Prasad JK
Burns; 1989 Jun; 15(3):190-2. PubMed ID: 2503000
[TBL] [Abstract][Full Text] [Related]
20. Development of an Experimental Ex Vivo Wound Model to Evaluate Antimicrobial Efficacy of Topical Formulations.
Andersson MÅ; Madsen LB; Schmidtchen A; Puthia M
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
